Other languages Collplant Holdings Ltd TEL AVIV STOCK EXCHANGE

Equities

CLGN

IL0004960188

Delayed TEL AVIV STOCK EXCHANGE Other stock markets			5-day change	1st Jan Change
- ^ILa	-.--%		-14.91%	-.--%

06-06	Collplant Successfully Bio-Prints 200Cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data	CI
05-29	Earnings Flash (CLGN) COLLPLANT Reports Q1 Revenue $98,000, vs. Street Est of $650,000	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Collplant Successfully Bio-Prints 200Cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data	06-06
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-29
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-04
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	01-02
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29
CollPlant Biotechnologies Issued US Patent for Photocurable Dermal Filler	11-01
Wall Street Set to Open Slightly Higher; Weekly Jobless Claims Fall to Near Historic Lows	19/10/23
Top Premarket Decliners	19/10/23
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
CollPlant to Receive $10 Million Milestone Payment From AbbVie Under Dermal Filler Product Deal; Shares Rise	26/06/23
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/05/23
Stratasys, CollPlant Biotechnologies to Bio-Fabricate Human Tissues, Organs	04/04/23
Stratasys Ltd. and Collplant Biotechnologies Ltd. to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs	04/04/23
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives	04/01/23
Collplant Enriches Portfolio of Rhcollagen-Based Bioinks with Launch of Collink.3Dtm 50L in Powder Form	03/01/23
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/12/22
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/12/22
Collplant Enters into A License and Research Agreement to Co-Develop A “Gut-On-A-Chip” Tissue Model for Drug Discovery and High Throughput Screening of Drugs	15/11/22
CollPlant Biotechnologies Ltd., Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis	15/11/22
Collplant Expands Rhcollagen-Based Bioink Platform with Launch of Collink.3D 90	07/11/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Collplant Holdings Ltd TEL AVIV STOCK EXCHANGE

Equities

CLGN

IL0004960188

Other languages

Filters